$3.33
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
CytomX Therapeutics (CTMX) Upgraded to Buy: Here's Why
Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now?
How The Narrative Around CytomX Therapeutics (CTMX) Is Evolving With Recent Developments
Overview
52-week range
$1.72
$8.21
25% of range
Avg surprise (last 3)
+59.5%
Avg reaction (last 2)
+63.2%
50% positive
Latest IV / EM
98%
EM ±22.5% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.10 | $-0.14 | +28.6% | -137.0% | -3.1% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | — | $-0.06 | +100.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $0.27 | $0.18 | +50.0% | — | +129.5% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.11 | — |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | — | $6M | $19M | $51M | — | $33M | $25M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-20M | — | $-16M | $-1M | $23M | — | $4M | $-8M |
| Net income | $-18M | — | $-14M | $-154,000 | $24M | — | $6M | $-7M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $29M | $13M | $34M | $49M | $48M | $38M | $41M | $43M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $353M | $144M | $149M | $165M | $87M | $107M | $124M | $143M |
| Total assets | $359M | $152M | $158M | $175M | $98M | $121M | $139M | $159M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $39M | $53M | $51M | $55M | $73M | $121M | $162M | $190M |
| Total equity | $320M | $99M | $107M | $120M | $25M | $-456,000 | $-23M | $-31M |